Phase 2 study of CHOP‑R‑14 followed by 90Y‑ibritumomab...

  • Main
  • 2017 / 02
  • Phase 2 study of CHOP‑R‑14 followed by 90Y‑ibritumomab...
Molecular and Clinical Oncology 2017 / 02

Phase 2 study of CHOP‑R‑14 followed by 90Y‑ibritumomab tiuxetan in patients with previously untreated diffuse large B‑cell lymphoma

Karmali, Reem, Larson, Melissa, Shammo, Jamile, Gregory, Stephanie, O'brien, Teresa, Venugopal, Parameswaran
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular and Clinical Oncology
DOI:
10.3892/mco.2017.1169
Date:
February, 2017
File:
PDF, 337 KB
english, 2017
Conversion to is in progress
Conversion to is failed